Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20074
20082
20096
20105
20119
20126
20132
20148
201512
20165
20175
20182
20194
20205
20215
20223
20235
20245
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status19
Recruiting12
Terminated12
Active, not recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche11
National Cancer Center, Korea11
Yonsei University7
Asan Medical Center6
Genentech, Inc.5
Pfizer5
Samsung Medical Center5
Bayer4
Seoul National University Hospital4
Gangnam Severance Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms106
Neoplasm Metastasis13
Triple Negative Breast Neoplasms9
Ovarian Neoplasms7
Colorectal Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Pancreatic Neoplasms5
Sarcoma5
Stomach Neoplasms5
Biliary Tract Neoplasms4

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.